Jw Life Science Corp (234080) — Cash Flow Quality Index
Jw Life Science Corp (234080) has a Cash Flow Quality Index of 0.79x as of December 2025. Operating cash flow of ₩5.08 Billion is below net income of ₩6.45 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 234080 cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jw Life Science Corp Cash Flow Quality Index (2015–2025)
Historical Cash Flow Quality Index for Jw Life Science Corp across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 234080 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Jw Life Science Corp (2015–2025)
Year-by-year earnings quality comparison for Jw Life Science Corp. For live market cap and the full company financial profile, see market value of Jw Life Science Corp.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.42x | ₩40.54 Billion | ₩28.61 Billion | ▲ +23.0% |
| 2024 | 1.15x | ₩50.69 Billion | ₩43.99 Billion | ▼ -13.7% |
| 2023 | 1.34x | ₩37.57 Billion | ₩28.14 Billion | ▲ +41.4% |
| 2022 | 0.94x | ₩14.13 Billion | ₩14.96 Billion | ▼ -59.6% |
| 2021 | 2.34x | ₩30.17 Billion | ₩12.91 Billion | ▲ +44.6% |
| 2020 | 1.62x | ₩46.75 Billion | ₩28.94 Billion | ▲ +48.8% |
| 2019 | 1.09x | ₩24.28 Billion | ₩22.35 Billion | ▼ -52.4% |
| 2018 | 2.28x | ₩36.13 Billion | ₩15.82 Billion | ▲ +73.8% |
| 2017 | 1.31x | ₩22.05 Billion | ₩16.78 Billion | ▲ +23.9% |
| 2016 | 1.06x | ₩16.08 Billion | ₩15.16 Billion | ▼ -47.3% |
| 2015 | 2.01x | ₩25.90 Billion | ₩12.86 Billion | — |